Survivin is a protein member of inhibitor of apoptosis (IAP), which is consistently elevated in prostate tumor-derived exosomes in comparison with benign prostatic hyperplasia and healthy controls (i.e., good sensitivity and specificity) [91]. Here, BIRC5 is linked to benign prostatic hyperplasia.